Group 1 - The core viewpoint of the article highlights the target price increases for several listed companies, with notable gains for Ningde Times, China Railway, and Shanghai Jahwa, reflecting strong market confidence in these sectors [1][2]. Group 2 - On January 29, the companies with the highest target price increases were Ningde Times (75.79%), China Railway (53.99%), and Shanghai Jahwa (52.17%), indicating significant bullish sentiment in the battery, infrastructure, and cosmetics industries respectively [1][2]. - A total of 27 listed companies received broker recommendations on January 29, with Qingdao Bank receiving the most recommendations at 5, followed by Mingyang Smart Energy and Ruoyuchen with 2 each [1][3]. - Three companies had their ratings upgraded on January 29, including TBEA, which was upgraded from "Hold" to "Buy" by Huatai Securities, reflecting improved outlooks for these firms [4][6]. - Five companies received initial coverage on January 29, with Qingdao Bank rated "Recommended" by Guolian Minsheng Securities, indicating new interest from analysts in these stocks [6][7].

Core Viewpoint - The controlling shareholder of Langzi Co., Ltd., Shen Dongri, has pledged 20.77 million shares of the company due to personal funding needs, raising concerns about the company's financial stability and operational performance [2][4]. Share Pledge Details - Shen Dongri pledged 9.5 million shares to China International Capital Corporation and 11.27 million shares to CITIC Securities, with the pledge starting on January 27, 2026, for one year [2][3]. - The pledged shares represent 36.61% of Shen's total holdings and 17.5% of the company's total equity [4]. Financial Performance - Langzi Co., Ltd. expects a net profit of 900 million to 1.05 billion yuan for 2025, a year-on-year increase of 245.25% to 302.8%, primarily due to investments in the listed company Ruoyuchen [4]. - The company reported a revenue of 4.328 billion yuan for the first three quarters of 2025, remaining stable year-on-year, while the net profit excluding non-recurring items is projected to be between 220 million and 290 million yuan, reflecting a modest increase of 1.09% to 33.25% [5]. Business Segment Performance - The medical beauty segment generated approximately 2.237 billion yuan in revenue, a year-on-year increase of 2.49%, but the corresponding net profit decreased by 33.49% to 77.198 million yuan [6]. - The women's clothing segment achieved revenue of 1.407 billion yuan, with a slight net profit increase of 1.62% to 99.143 million yuan, while online sales grew by 22.55% [6]. - The infant and child segment reported revenue of 674 million yuan, with net profit declining significantly compared to the previous year [6]. Inventory and Financial Health - As of September 2025, the company's inventory for women's clothing reached approximately 630 million yuan, a 13.84% increase from the end of 2024, indicating rising inventory levels [6]. - The company faces financial pressure, with cash reserves of 505 million yuan insufficient to cover short-term borrowings of 1 billion yuan [10]. Strategic Moves - Langzi Co., Ltd. is accelerating its investment in the medical beauty sector, including a recent acquisition of a 67.5% stake in a cosmetic surgery hospital for 92.475 million yuan [7][8].

Core Viewpoint - The controlling shareholder of Langzi Co., Ltd. has pledged 20.77 million shares due to personal funding needs, raising concerns about the company's financial stability and operational performance [1][3]. Share Pledge Details - The pledged shares include 9.5 million shares to China International Capital Corporation and 11.27 million shares to CITIC Securities, with a pledge period starting from January 27, 2026, for one year [1][2]. - The total pledged shares represent 36.61% of the shareholder's holdings and 17.5% of the company's total equity [3]. Financial Performance - Langzi Co., Ltd. expects a net profit of 900 million to 1.05 billion yuan for 2025, a significant increase of 245.25% to 302.8% year-on-year, primarily due to investment gains from Ruoyuchen [6]. - The company's revenue for the first three quarters of 2025 was 4.328 billion yuan, remaining stable compared to the previous year, while the net profit excluding non-recurring items decreased by 4.11% [6][7]. Business Segments - The medical beauty segment generated approximately 2.237 billion yuan in revenue, a 2.49% increase year-on-year, but the corresponding net profit decreased by 33.49% [7]. - The women's clothing segment achieved revenue of 1.407 billion yuan, with a slight net profit increase of 1.62% [7]. - The children's wear segment contributed 674 million yuan in revenue, showing a decline compared to the previous year [7]. Inventory and Cash Flow - As of September 2025, the company's inventory for women's clothing reached approximately 630 million yuan, a 13.84% increase from the end of 2024 [7]. - The company's cash flow from operating activities decreased by 1.87% to 359 million yuan [6]. Strategic Moves - Langzi Co., Ltd. is accelerating its investment in the medical beauty sector, including a recent acquisition of a 67.5% stake in a cosmetic surgery hospital for 92.475 million yuan [8][9]. - The company controls four comprehensive hospitals and two outpatient departments, with plans to integrate these medical beauty institutions into its financial statements [9]. Financial Constraints - As of September 2025, the company's cash reserves were 505 million yuan, insufficient to cover short-term borrowings of 1 billion yuan [11].

Group 1: New Consumption - Ruoyuchen (003010.SZ) - The company expects a net profit attributable to shareholders of 176 million to 200 million yuan for 2025, representing a year-on-year growth of 66.61%-89.33% [2][5] - The significant growth in performance is primarily driven by rapid revenue growth from proprietary brands, high performance in brand management, and effective cost reduction strategies [6][7] - The company has established a competitive advantage in various categories such as health products, maternal and infant care, beauty and personal care, and food and beverages, with plans to continue expanding its proprietary brand portfolio [6][7] Group 2: Transportation - Haifeng International (01308.HK) - The company anticipates a net profit attributable to shareholders of 1.2 to 1.23 billion USD for 2025, reflecting a year-on-year increase of approximately 16%-18.9% [9][12] - The company has built a differentiated advantage through a high-frequency, point-to-point direct shipping network, which supports performance growth amid stable demand for container trade in Asia [9][10] - The expected container volume for 2025 is approximately 3.85 million TEU, with an average revenue per container of about 753.0 USD/TEU, indicating a year-on-year increase of approximately 4.4% [9][10] Group 3: Transportation - Southern Airlines (600029.SH) - The company is expected to have a fleet size of 972 aircraft by the end of 2025, maintaining a high passenger load factor of 85.7%, which is an increase of 1.36 percentage points year-on-year [13][14] - The focus on international routes is expected to drive an 18.5% year-on-year growth in international available seat kilometers (ASK), leading to potential market share expansion [13][14] - The company has shown continuous improvement in operations, with a projected passenger volume of 174 million for 2025, representing a year-on-year growth of 5.5% [14][15]

Core Viewpoint - The internet e-commerce sector experienced a slight increase of 0.47% on January 29, with 壹网壹创 leading the gains, while the overall market showed mixed results with the Shanghai Composite Index rising by 0.16% and the Shenzhen Component Index declining by 0.3% [1]. Group 1: Market Performance - The internet e-commerce sector's performance was highlighted by 壹网壹创, which closed at 42.68 with a rise of 5.88% and a trading volume of 310,300 shares [1]. - Other notable performers included ST通葡, which increased by 2.33% to close at 3.07, and 凯淳股份, which rose by 1.65% to 36.39 [1]. - The overall trading volume for the internet e-commerce sector was significant, with individual stocks like 华凯易佰 and 焦点科技 achieving trading volumes of 327,100 and 141,200 shares respectively [1]. Group 2: Capital Flow - The net inflow of main funds into the internet e-commerce sector was 134 million yuan, while retail funds saw a net inflow of 989,400 yuan [2]. - Conversely, speculative funds experienced a net outflow of 135 million yuan, indicating a shift in investment strategies among different types of investors [2]. - The capital flow data showed that 壹网壹创 had a main fund net inflow of 125 million yuan, despite a net outflow from speculative and retail investors [3]. Group 3: Individual Stock Analysis - 壹网壹创 led the sector with a main fund net inflow of 125 million yuan, representing 9.24% of its trading volume [3]. - 焦点科技 and 青木科技 also saw significant main fund inflows of 45.09 million yuan and 26.03 million yuan respectively, indicating strong investor interest [3]. - In contrast, ST通葡 experienced a negative main fund flow of 1.20 million yuan, reflecting weaker investor confidence [3].

| GUOTAI HAITONG SECURITIES | | --- | | 国泰海通证券 | 精 选 目 录 | | 每日报告精选（2026-01-28 09:00——2026-01-29 15:00） 2 | | --- | --- | |  | 宏观专题：《美联储如期按兵不动》2026-01-29 2 | |  | 宏观专题：《白银牛市：价格破 怎么看》2026-01-28 3 100 | |  | 行业专题研究：计算机《制度闭环叠加 催化，迎接数据要素"价值释放年"》2026-01-28 3 AI | |  | 行业专题研究：可选消费品《智能眼镜产品力系列二：大模型催化，AI 眼镜异军突起评》2026-01-28 4 | |  | 行业专题研究：耐用消费品《3D 打印行业：产业浪潮已至，工业消费双向驱动》2026-01-28 5 | |  | 公司跟踪报告：中国中铁（601390）《铜钼矿产待重估，承建海南商业航天发射场》2026-01-29 6 | |  | 公司信息点评：长盈精密（300115）《股权激励落地绑定核心成员，机器人业务前景广阔》2026-01-29 7 | |  | ...

Investment Rating - The investment rating for the company is "Accumulate" (maintained) [4] Core Views - The company's performance forecast for 2025 aligns with expectations, with proprietary brand revenue expected to achieve high growth [4] - Significant growth in net profit is anticipated due to rapid revenue growth from proprietary brands, strong performance in brand management, and effective cost reduction strategies [6] - The company has established a competitive advantage in various categories, including health products, maternal and infant care, beauty and personal care, and food and beverages, which may further enhance growth potential [6] Financial Summary - Revenue projections for the company are as follows: - 2023: 1,366 million RMB - 2024: 1,766 million RMB (growth of 29.26%) - 2025: 2,934 million RMB (growth of 66.14%) - 2026: 4,374 million RMB (growth of 49.11%) - 2027: 5,401 million RMB (growth of 23.47%) [5] - Net profit forecasts are as follows: - 2023: 54 million RMB - 2024: 106 million RMB (growth of 94.58%) - 2025: 190 million RMB (growth of 79.67%) - 2026: 327 million RMB (growth of 72.07%) - 2027: 459 million RMB (growth of 40.51%) [5] - Earnings per share (EPS) projections are: - 2023: 0.17 RMB - 2024: 0.34 RMB - 2025: 0.61 RMB - 2026: 1.05 RMB - 2027: 1.48 RMB [5] Business Strategy - The company is focusing on enhancing its proprietary brand business, with successful product launches contributing to revenue growth [6] - The brand management business is also expected to see significant performance improvements through deep collaborations with multiple brands [6] - The company is implementing a refined operational strategy to optimize costs across various dimensions, including supply chain management and marketing [6]

业绩高增，自有品牌延续高势能 glmszqdatemark 事件：1 月 27 日公司发布 2025 年业绩预告，2025 年预计实现归母净利润 1.76 亿元-2.00 亿元，同增 67%-89%，扣非归母净利润 1.70-1.94 亿元，同增 60%-83%。其中 2025Q4 预计实现归母净利润 0.71-0.95 亿元，同增 49%-99%， 扣非归母净利润 0.68-0.92 亿元，同增 39%-87%。 自有品牌与品牌管理业绩释放，内部管理精益提效。根据公司公告，业绩增长的 主要原因如下：1）自有品牌收入高增：绽家在保持多款单品在细分领域的领先优 势基础上推出战略单品香氛洗衣液，上市后实现快速放量；斐萃在产品端、渠道 端持续发力，推动收入高增。2）品牌管理业绩高增：与多品牌深度合作，进一步 巩固公司在全链路、全渠道数字化服务领域的领先地位。3）内部管理：2025 年 公司持续推进精细化运营战略，降低运营成本，提升资源利用效率。此外，2026 年 1 月 1 日起公司与美斯蒂克正式达成长期战略合作伙伴关系，后续有望将以自 身在全渠道布局、全链路营销推广等方面的核心优势，全面赋能美斯蒂克在中国 市场的 ...

若羽臣（003010.SZ）2025 年业绩预告点评 业绩高增，自有品牌延续高势能 glmszqdatemark 事件：1 月 27 日公司发布 2025 年业绩预告，2025 年预计实现归母净利润 1.76 亿元-2.00 亿元，同增 67%-89%，扣非归母净利润 1.70-1.94 亿元，同增 60%-83%。其中 2025Q4 预计实现归母净利润 0.71-0.95 亿元，同增 49%-99%， 扣非归母净利润 0.68-0.92 亿元，同增 39%-87%。 自有品牌与品牌管理业绩释放，内部管理精益提效。根据公司公告，业绩增长的 主要原因如下：1）自有品牌收入高增：绽家在保持多款单品在细分领域的领先优 势基础上推出战略单品香氛洗衣液，上市后实现快速放量；斐萃在产品端、渠道 端持续发力，推动收入高增。2）品牌管理业绩高增：与多品牌深度合作，进一步 巩固公司在全链路、全渠道数字化服务领域的领先地位。3）内部管理：2025 年 公司持续推进精细化运营战略，降低运营成本，提升资源利用效率。此外，2026 年 1 月 1 日起公司与美斯蒂克正式达成长期战略合作伙伴关系，后续有望将以自 身在全渠道布局、全链路营 ...

Summary of Conference Call Notes Company Overview - The company discussed is **倍加洁** (Beijiajie), which operates in the **probiotic and dietary supplement industry**. The focus is on its subsidiary **善恩康** (Shanenkang) and its product line involving **AKK菌** (Akkermansia muciniphila). Key Points and Arguments - **Stock Price Volatility**: The company's stock experienced significant fluctuations, attributed to a general pullback in small-cap stocks within the beauty and health sector. However, the company's fundamentals remain strong, with no abnormalities reported [1]. - **Growth Projections**: The company anticipates stable growth in its contract manufacturing business through 2026. The subsidiary Shanenkang is expected to see rapid growth driven by the AKK菌 product line, with profit margins likely to improve [1]. - **Financial Performance**: For the first half of 2025, Shanenkang is projected to achieve revenue of **49.76 million yuan**, representing an increase of over **80%** year-on-year. The net profit is expected to be **8.38 million yuan**, with a net profit margin of approximately **17%** (compared to a loss in the same period of 2024) [1]. - **Customer Expansion**: The significant revenue growth is attributed to an increase in customer numbers and the successful launch of high-margin AKK菌 products. The company has established partnerships with brands such as **仙乐** (Xianle), **Wonderlab**, and **若羽臣** (Ruoyuchen) [1]. - **Revenue Forecast for AKK菌**: The company estimates that revenue from AKK菌 products will exceed **10 million yuan** in 2025, with expectations for exponential growth in 2026 [1]. Industry Insights - **AKK菌 Overview**: AKK菌, also known as "slim bacteria" or "longevity bacteria," is naturally found in the human gut and is associated with higher proportions in long-lived and lean populations. It has significant potential applications in enhancing metabolism and immune health [2]. - **Product Development**: In February 2025, Shanenkang's AKK PROBIO active probiotic became the first product globally to receive both live and inactivated bacteria GRAS certification from the U.S. [2]. - **Market Trends**: There has been a surge in dietary supplement brands launching AKK菌 products. For instance, **若羽臣** launched an AKK菌 product priced at **228 yuan** per bottle, focusing on scientific weight management and metabolism enhancement, achieving over **4 million yuan** in GMV within 20 days of launch [2]. - **Competitive Landscape**: Recently, the **斐萃** brand introduced the **AKK小银瓶** product, priced at **2997 yuan** for three bottles, each containing **100 billion TFU** of inactivated AKK菌. This indicates a growing market interest and application potential for AKK菌 products [2]. Additional Important Content - The ongoing development and marketing of AKK菌 products suggest a promising future for the probiotic segment, with increasing consumer awareness and demand for health supplements focusing on metabolic and immune health benefits [2].